(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 5.02% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Teleflex's revenue in 2024 is $2,974,489,000.On average, 14 Wall Street analysts forecast TFX's revenue for 2024 to be $145,572,991,586, with the lowest TFX revenue forecast at $144,821,499,568, and the highest TFX revenue forecast at $146,208,254,093. On average, 14 Wall Street analysts forecast TFX's revenue for 2025 to be $153,681,858,677, with the lowest TFX revenue forecast at $151,773,624,219, and the highest TFX revenue forecast at $155,408,266,888.
In 2026, TFX is forecast to generate $162,199,928,935 in revenue, with the lowest revenue forecast at $159,781,696,325 and the highest revenue forecast at $165,042,611,013.